title: Research resources for tuberculosis at the National Institute of Allergy and Infectious Diseases.
abstract: Global control of tuberculosis (TB) requires the participation of multiple stakeholders that cross the spectrum of biomedical research, product development, and implementation and operational research. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), plays a critical role in TB biomedical research and product development by directly supporting and leveraging other funding support strategies and providing research resources to facilitate the translation of knowledge about TB into strategies and tools to more effectively combat disease. The primary mission of NIAID is to support high quality, peer reviewed, investigator initiated research that contributes to innovation in infectious disease research. It is also within the mission of NIAID to assure that research findings are translated into vaccines, diagnostics, and drugs to better prevent, diagnose, and treat this devastating disease.
mesh_terms: D035843:Biomedical Research / Q000379:methods*; D019295:Computational Biology / Q000379:methods; D055808:Drug Discovery / Q000379:methods; D023281:Genomics / Q000379:methods; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D054579:National Institute of Allergy and Infectious Diseases (U.S.); D012109:Research Support as Topic; D014376:Tuberculosis / Q000175:diagnosis / Q000628:therapy*; D014481:United States